The Role of Radioactive Iodine-125 Particles in EMT and Clinical Treatment of Lung Adenocarcinoma

Fei SONG; Jiayin CHE; Ming HUANG; Dan XU; Hongyang LI; Dingkun LI; Yingying XIANG

doi:10.12259/j.issn.2095-610X.S20230101

Volume 44 Issue 1

Jan. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2023 > 44(1): 140-143

Fei SONG, Jiayin CHE, Ming HUANG, Dan XU, Hongyang LI, Dingkun LI, Yingying XIANG. The Role of Radioactive Iodine-125 Particles in EMT and Clinical Treatment of Lung Adenocarcinoma[J]. Journal of Kunming Medical University, 2023, 44(1): 140-143. doi: 10.12259/j.issn.2095-610X.S20230101

Citation:

Fei SONG, Jiayin CHE, Ming HUANG, Dan XU, Hongyang LI, Dingkun LI, Yingying XIANG. The Role of Radioactive Iodine-125 Particles in EMT and Clinical Treatment of Lung Adenocarcinoma[J]. Journal of Kunming Medical University, 2023, 44(1): 140-143. doi: 10.12259/j.issn.2095-610X.S20230101

Citation:

Fei SONG, Jiayin CHE, Ming HUANG, Dan XU, Hongyang LI, Dingkun LI, Yingying XIANG. The Role of Radioactive Iodine-125 Particles in EMT and Clinical Treatment of Lung Adenocarcinoma[J]. Journal of Kunming Medical University, 2023, 44(1): 140-143. doi: 10.12259/j.issn.2095-610X.S20230101

PDF( 541 KB)

The Role of Radioactive Iodine-125 Particles in EMT and Clinical Treatment of Lung Adenocarcinoma

doi: 10.12259/j.issn.2095-610X.S20230101

1.
Dept. of Invasive Intervention，The 3rd Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital，Kunming Yunnan 650118
2.
Dept. of Medical Laboratory，Pingbian Miao Autonomous County People’s Hospital，Pingbian Yunnan，661200
3.
Dept. of Hepatobiliary and Pancreatic Surgery，The 3rd Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital，Kunming Yunnan 650118
4.
Dept. of Stomatology，Yan’an Hospital of Kunming City，Kunming Yunnan 650051，China

Received Date: 2022-10-14
Publish Date: 2023-01-25

Abstract

Abstract

Lung cancer is one of the most common tumors, and Yunnan has the highest incidence of lung cancer in China. Many patients are diagnosed with advanced lung cancer and are treated with a combination of chemotherapy, radiotherapy, targeted therapy, immunotherapy, and local therapy （ablation, freezing, ¹²⁵I, etc.）. As one of the local treatment methods for advanced lung cancer, radioactive ¹²⁵I seed implantation has its unique advantages, such as small radiation radius, specific irradiation targeting of the lesion, and little damage to surrounding normal tissue, and good clinical effect. Studies have shown that epithelial mesenchymaltransformation （EMT） with lung adenocarcinoma is closely related to the growth, invasion, and metastasis. This article discusses the role of radioactive ¹²⁵I particles in EMT and clinical treatment of lung adenocarcinoma
- Lung adenocarcinoma,
- Epithelial-mesenchymal transformation,
- Radioactive iodine-125 particles

FullText(HTML)

References(21)

References

[1]	路友华,王炳翔,王家林,等. 中国居民1990-2019年肺癌及其危险因素疾病负担变化趋势分析[J]. 中国公共卫生,2022,38(5):513-517.
[2]	Zhuang H,Shi S,Guo Y,et al. Increase of secondary mutations may be a drug-resistance mechanism for lung adenocarcinoma after radiation therapy combined with tyrosine kinase inhibitor[J]. J Cancer,2019,10(22):5371-5376. doi: 10.7150/jca.35247
[3]	Tian X,Gu T,Lee M H,et al. Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer[J]. Biochim Biophys Acta Rev Cancer,2022,1877(1):188645. doi: 10.1016/j.bbcan.2021.188645
[4]	Wu F,Ji A,Zhang Z,et al. miR-491-5p inhibits the proliferation and migration of A549 cells by FOXP4[J]. Exp Ther Med,2021,21(6):622. doi: 10.3892/etm.2021.10054
[5]	Song J,Fan X,Zhao Z,et al. (125)I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy:A comparison with best supportive care[J]. Onco Targets Ther,2017,10(3):1345-1352.
[6]	Tang B,Xi Y,Cui F,et al. Ionizing radiation induces epithelial-mesenchymal transition in human bronchial epithelial cells[J]. Biosci Rep,2020,40(8):BSR20200453. doi: 10.1042/BSR20200453
[7]	Uribe M L,Marrocco I,Yarden Y. EGFR in Cancer: Signaling mechanisms, drugs, and acquired resistance[J]. Cancers (Basel),2021,13(11):2748. doi: 10.3390/cancers13112748
[8]	Matsubara T,Tagawa T,Takada K,et al. Clinical and prognostic significance of the epithelial-mesenchymal transition in stage IA lung adenocarcinoma:A propensity score-matched analysis[J]. Clin Lung Cancer,2019,20(4):e504-e513. doi: 10.1016/j.cllc.2019.04.006
[9]	Yu J J,Zhou D D,Yang X X,et al. TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target[J]. Nat Commun,2020,11(1):3660. doi: 10.1038/s41467-020-17385-0
[10]	Thompson J C,Hwang W T,Davis C,et al. Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy[J]. Lung Cancer,2020,139(10):1-8.
[11]	刘登尧,叶尔麦克·阿哈提,李建邦. 放射性125碘粒子对肺腺癌A549细胞荷瘤裸鼠HIF-1α表达的影响[J]. 新疆医科大学学报,2021,44(2):133-136.
[12]	He Y,Li L,Liu J,et al. Iodine-125 seed brachytherapy inhibits non-small cell lung cancer by suppressing epithelial-mesenchymal transition[J]. Brachytherapy,2018,17(4):696-701. doi: 10.1016/j.brachy.2018.03.002
[13]	Sui A,Song H,Yu H,et al. Clinical application of iodine-125 seed brachytherapy combined with anti-PD-1 antibodies in the treatment of lung cancer[J]. Clin Ther,2020,42(8):1612-1616. doi: 10.1016/j.clinthera.2020.05.018
[14]	Chen C,Wang W,Yu Z,et al. Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy[J]. Lung Cancer,2020,146(6):290-296.
[15]	吴春蓉,李波,向德兵,等. 碘-125粒子植入近距离放疗联合化疗治疗老年晚期非小细胞肺癌的临床研究[J]. 广西医学,2020,42(19):2487-2491.
[16]	姚雪原,郭彦伟,张红巧,等. CT引导下~(125)I粒子植入联合化疗治疗中晚期非小细胞肺癌的疗效及安全性研究[J]. 微创医学,2022,17(4):441-444.
[17]	田冲. 放射性碘125粒子植入联合全身化疗治疗晚期肺癌患者近远期疗效观察[J]. 医学理论与实践,2021,34(6):907-909.
[18]	Hong J,Shi Y B,Fu Y F,et al. Iodine-125 seeds insertion with trans-arterial chemical infusion for advanced lung cancer:a meta-analysis[J]. J Contemp Brachytherapy,2022,14(4):403-410.
[19]	张忠亮,肖越勇,张肖,等. ~(125)I粒子植入术联合支气管动脉化疗栓塞治疗纵隔型肺癌和/或肿瘤纵隔淋巴结转移[J]. 中国介入影像与治学,2022,19(12):756-760.
[20]	Ji Z ,Jiang Y ,Guo F ,et al. Safety and efficacy of CT-guided radioactive iodine-125 seed implantation assisted by a 3D printing template for the treatment of thoracic malignancies[J]. J Cancer Res Clin Oncol,2020,146(1):229-236. doi: 10.1007/s00432-019-03050-7
[21]	何禹. 碘-125粒子组织间植入联合支气管动脉灌注化疗治疗肺癌的疗效观察[J]. 医学食疗与健康,2022,20(15):43-45.

Relative Articles(20)

Relative Articles

[1]	Shengqiang YANG, Ping WANG. Effect of Hsp90 Inhibitor Ganetespib Combined with Pemetrexed on Lung Adenocarcinoma Cells. Journal of Kunming Medical University, 2024, 45(7): 30-41. doi: 10.12259/j.issn.2095-610X.S20240705
[2]	Hongxiu YANG, Zhongshan ZHU. Effect of HPRT1 Gene Expression on Overall Survival of Patients with Lung Adenocarcinoma. Journal of Kunming Medical University, 2024, 45(8): 17-23. doi: 10.12259/j.issn.2095-610X.S20240803
[3]	Wangxun SHEN, Yinyu YANG, Canwei LI, Jinrong YANG, Sijing WU, Huajun ZHAO, Xiaoyu TUO. Expression and Clinical Significance of ROR1 in Different Histologic Types of Invasive Lung Adenocarcinoma. Journal of Kunming Medical University, 2024, 45(5): 60-65. doi: 10.12259/j.issn.2095-610X.S20240509
[4]	Dongxing XU, Bo TANG, Guo ZHU, Xuefen LEI, Qiuhong WANG, Dong WEI. Effect and Mechanism of Twist1 Regulating Bmi1 on Invasion and Migration of Gallbladder Carcinoma Cells. Journal of Kunming Medical University, 2023, 44(3): 28-33. doi: 10.12259/j.issn.2095-610X.S20230320
[5]	Shiqi MA, Yi DING, Min LI, Mengci WANG, Siyu ZHANG, Shumei FENG. LINC00341 Inhibits the Proliferation of Lung Adenocarcinoma Cells Through the MAPK Pathway. Journal of Kunming Medical University, 2023, 44(4): 1-8. doi: 10.12259/j.issn.2095-610X.S20230403
[6]	Bangqing LIU, Jianfeng LI, Xiaohui LIU, Jinnan ZHANG, Jinping LIANG. MiR-196b Promotes Proliferation and Migration of Lung Adenocarcinoma by Targeting ERG. Journal of Kunming Medical University, 2023, 44(10): 83-91. doi: 10.12259/j.issn.2095-610X.S20231023
[7]	Yao ZOU, Ziyu WANG, Jiao LI, Xingxin LI, Yaqiong SHEN, Jing XU, Yan JIN. Association between LOXL2 and Snail Expression Levels and Overall Survival Rate after Surgery in Patients with Cholangiocarcinoma. Journal of Kunming Medical University, 2022, 43(12): 81-87. doi: 10.12259/j.issn.2095-610X.S20221215
[8]	Maofang WU, Yongchun ZHOU, Jingjing CAI, Xin MO, Yinwei LI, Jiahui MAO. EGFR Gene Mutation State and Its Clinical Significance in Multi-nodular Lung Adenocarcinoma in Yunnan Province. Journal of Kunming Medical University, 2022, 43(2): 60-66. doi: 10.12259/j.issn.2095-610X.S20220215
[9]	Zhongshan ZHU, Zhou YANG, Chengchuan JIANG, Xiaobing LI, Dou REN, Cheng HUANG, Weiwei ZHANG, Xiangjun LI, Shunli ZHAO. An Analysis of PLA2G1B Expression and Prognosis in Patients with Lung Adenocarcinoma. Journal of Kunming Medical University, 2022, 43(9): 70-76. doi: 10.12259/j.issn.2095-610X.S20220912
[10]	Huajun ZHAO, Guoqing PAN, Ying TANG, Zhiyuan WANG, Xiaowei ZHAO, Xiaoyu TUO. Expressions of ROR1 in Lung Adenocarcinoma and Its Relationship with Spread Through Air Apace. Journal of Kunming Medical University, 2022, 43(11): 22-29. doi: 10.12259/j.issn.2095-610X.S20221128
[11]	Ying-xia WANG, Qin HE, Guo-fang WANG, Xuan ZHANG. Expression and Significance of microRNA-21 and EGFR in Non-small Cell Lung Cancer. Journal of Kunming Medical University, 2021, 42(8): 101-105. doi: 10.12259/j.issn.2095-610X.S20210818
[12]	Ai-ping XU, Hua LIN, Li-hui GAO, Ling LI, Meng-wei CHENG, Ge WANG, Juan YANG, Yan-fen NIU. Effect of Norathyriol on the Epithelial-mesenchymal Transition of HK-2 Cells Induced by TGF-β1. Journal of Kunming Medical University, 2021, 42(7): 1-6. doi: 10.12259/j.issn.2095-610X.S20210701
[13]	Hong-min DUAN, Nan CHEN, Yong-yan YANG, Yun-xia LI, Jin-xiang FENG, Hang LI, Xiu-wen HUANG, Dong-jin LV, Ming ZHANG, Yu-tao ZHAO. Effects and Mechanism of Anlotinib on Radiosensitivity of Non-small Cell Lung Cancer Cell Lines A549. Journal of Kunming Medical University, 2021, 42(8): 40-46. doi: 10.12259/j.issn.2095-610X.S20210808
[14]	Yan-fen MA, Jian HU, Ning ZHANG, Qian WU, Xiao-qin WANG. Changes and Abnormal Patterns of Coagulation Indicators in Patients with Lung Adenocarcinoma and Tuberculosis Pleural Effusion. Journal of Kunming Medical University, 2021, 42(10): 145-150. doi: 10.12259/j.issn.2095-610X.S20211021
[15]	Ma Guo Yu , Xiong Qing , Jiang Guo Qing , Yang Jia Tian , Mu Yun Zhen . . Journal of Kunming Medical University, 2020, 41(07): 30-37.
[16]	Wu Qi Yan , Bian Ge Yuan , Cheng Hui Jun, Li Jiao Xia , Wang Shu Ting , Huang Zhao Lue . . Journal of Kunming Medical University, 2020, 41(09): 32-37.
[17]	Zhu Zhong Shan , Yan Wen Hui , Li Xiao Bing , Yang Zhou , Bai Peng . Driver Genes Mutation and Survival Analysis in 200 Patients with Pulmonary Adenocarcinoma Brain Metastasis. Journal of Kunming Medical University, 2018, 39(08): 47-50.
[18]	Zhao Bin , Li Rui Qian , Zhang Guo Ying , Lei Yong Hong , Wang Qi Lin , Liu Zhi Min . Overexpression of miR-4328 Inhibits the Proliferation, Migration and Epithelial Mesenchymal Transition of Prostate Cancer Cells. Journal of Kunming Medical University, 2017, 38(11): 29-33.
[19]	Wang Hua . . Journal of Kunming Medical University,
[20]	. Expression of study of Nestin in Lung Adenocarcinoma Cell Line A549. Journal of Kunming Medical University,